Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MGI-114 in Stage IV Malignant Melanoma
NCT00005968Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 1999
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irofulven in Malignant Melanoma (MM), sponsored by University of Colorado Denver. Started Nov 1999; status: completed.
02
Drugs
irofulven
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00005968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005968.